SANOFI CONS HEALTHC IND L - Asset Resilience Ratio

Latest as of December 2025: 0.07%

SANOFI CONS HEALTHC IND L (SANOFICONR) has an Asset Resilience Ratio of 0.07% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

Rs4.00 Million

≈ $43.26K USD Cash + Short-term Investments

Total Assets

Rs5.47 Billion

≈ $59.16 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2024–2025)

This chart shows how SANOFI CONS HEALTHC IND L's Asset Resilience Ratio has changed over time. See SANOFICONR financial flexibility score to measure the company's free cash flow as a share of total liabilities.

Liquid Assets Composition Over Time

This chart breaks down SANOFI CONS HEALTHC IND L's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see SANOFI CONS HEALTHC IND L (SANOFICONR) total market value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs0.00	0%
Short-term Investments	Rs4.00 Million	0.07%
Total Liquid Assets	Rs4.00 Million	0.07%

Asset Resilience Insights

Limited Liquidity: SANOFI CONS HEALTHC IND L maintains only 0.07% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

SANOFI CONS HEALTHC IND L Industry Peers by Asset Resilience Ratio

Compare SANOFI CONS HEALTHC IND L's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biogen Inc NASDAQ:BIIB	Drug Manufacturers - General	2.74%
Pfizer Inc SA:PFIZ34	Drug Manufacturers - General	5.48%
AstraZeneca PLC NYSE:AZN	Drug Manufacturers - General	0.10%
Zhangzhou Pientzehuang Pharmaceutical Co Ltd SHG:600436	Drug Manufacturers - General	17.40%
Aurora Optoelectronics Co Ltd SHG:600666	Drug Manufacturers - General	5.89%
NanJing Pharmaceutical Co Ltd SHG:600713	Drug Manufacturers - General	0.85%
Dimed S.A. Distribuidora de Medicamentos SA:PNVL3	Drug Manufacturers - General	7.83%
Firebrick Pharma Ltd AU:FRE	Drug Manufacturers - General	0.29%

Annual Asset Resilience Ratio for SANOFI CONS HEALTHC IND L (2024–2025)

The table below shows the annual Asset Resilience Ratio data for SANOFI CONS HEALTHC IND L.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	0.07%	Rs4.00 Million ≈ $43.26K	Rs5.47 Billion ≈ $59.16 Million	-0.81pp
2024-12-31	0.88%	Rs38.00 Million ≈ $410.96K	Rs4.31 Billion ≈ $46.64 Million	--

pp = percentage points

About SANOFI CONS HEALTHC IND L

NSE:SANOFICONR India Drug Manufacturers - General

Market Cap

$1.13 Billion

Rs104.55 Billion INR

Market Cap Rank

#8279 Global

#416 in India

Share Price

Rs4539.50

Change (1 day)

-1.55%

52-Week Range

Rs3999.50 - Rs5366.50

All Time High

Rs5696.00